Literature DB >> 22108732

Diabetes and the risk of heart failure.

Ravi Dhingra1, Ramachandran S Vasan.   

Abstract

Prevalence of diabetes and heart failure are increasing exponentially worldwide. Diabetes is well-known to increase the risk of heart failure independent of other traditional risk factors and ischemia. Current evidence indicates the presence of several biochemical and molecular changes associated with diabetes that lead to diastolic dysfunction or American Heart Association stage B heart failure. Some, if not all, changes may also predate the development of frank diabetes. In this review, the authors present some of the epidemiologic evidence and a brief description of major mechanistic pathways that favor the development of heart failure in prediabetic and diabetic states. 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22108732      PMCID: PMC3223386          DOI: 10.1016/j.hfc.2011.08.008

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  114 in total

1.  A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension.

Authors:  M Kawaguchi; M Techigawara; T Ishihata; T Asakura; F Saito; K Maehara; Y Maruyama
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients.

Authors:  P T Monteagudo; V A Moisés; O Kohlmann; A B Ribeiro; V C Lima; M T Zanella
Journal:  Clin Cardiol       Date:  2000-05       Impact factor: 2.882

3.  Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.

Authors:  S S Franklin; S A Khan; N D Wong; M G Larson; D Levy
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

4.  Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up.

Authors:  J Arnlöv; L Lind; B Zethelius; B Andrén; C N Hales; B Vessby; H Lithell
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men.

Authors:  J Sundström; L Lind; N Nyström; B Zethelius; B Andrén; C N Hales; H O Lithell
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

7.  Insulin resistance and risk of congestive heart failure.

Authors:  Erik Ingelsson; Johan Sundström; Johan Arnlöv; Björn Zethelius; Lars Lind
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

8.  Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance.

Authors:  P H McNulty; R J Louard; L I Deckelbaum; B L Zaret; L H Young
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

9.  Predictors of heart failure among women with coronary disease.

Authors:  Kirsten Bibbins-Domingo; Feng Lin; Eric Vittinghoff; Elizabeth Barrett-Connor; Stephen B Hulley; Deborah Grady; Michael G Shlipak
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

Review 10.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

View more
  30 in total

Review 1.  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction.

Authors:  Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

Review 2.  Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.

Authors:  Frank P Brouwers; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2012-12

3.  Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice.

Authors:  Cong Wang; Fan Fan; Quan Cao; Cheng Shen; Hong Zhu; Peng Wang; Xiaona Zhao; Xiaolei Sun; Zhen Dong; Xin Ma; Xiangwei Liu; Shasha Han; Chaoneng Wu; Yunzeng Zou; Kai Hu; Junbo Ge; Aijun Sun
Journal:  J Mol Med (Berl)       Date:  2016-08-03       Impact factor: 4.599

Review 4.  Nutraceuticals: Reviewing their Role in Chronic Disease Prevention and Management.

Authors:  Amanda Bergamin; Evangeline Mantzioris; Giordana Cross; Permal Deo; Sanjay Garg; Alison M Hill
Journal:  Pharmaceut Med       Date:  2019-08

Review 5.  The emerging epidemic of heart failure with preserved ejection fraction.

Authors:  A Afşin Oktay; Jonathan D Rich; Sanjiv J Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 6.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

7.  Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease.

Authors:  Stephen J Horgan; Chris J Watson; Nadia Glezeva; Pat Collier; Roisin Neary; Isaac J Tea; Niamh Corrigan; Mark Ledwidge; Ken McDonald; John A Baugh
Journal:  J Cardiovasc Transl Res       Date:  2015-11-17       Impact factor: 4.132

8.  HbA1c and heart failure risk among diabetic patients.

Authors:  Wenhui Zhao; Peter T Katzmarzyk; Ronald Horswell; Yujie Wang; Jolene Johnson; Gang Hu
Journal:  J Clin Endocrinol Metab       Date:  2013-01-01       Impact factor: 5.958

9.  Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Authors:  Selma F Mohammed; Barry A Borlaug; Véronique L Roger; Sultan A Mirzoyev; Richard J Rodeheffer; Julio A Chirinos; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2012-10-17       Impact factor: 8.790

Review 10.  Growth differentiation factor 15 in heart failure: an update.

Authors:  Kai C Wollert; Tibor Kempf
Journal:  Curr Heart Fail Rep       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.